TVM raises E336m for life science

The German-US venture capitalist has closed TVM Life Science V well above its initial E250m target, indicating that investor demand for biotech is holding up well.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this